The management of atrial fibrillation can be challenging in patients receiving BTK inhibitors as the treatment of atrial fibrillation often includes anticoagulants, which can exacerbate the bleeding risk already associated with BTK inhibitors. Here, BTK is linked to atrial fibrillation.